Integra LifeSciences Prices $450M Senior Notes
Integra LifeSciences announced the pricing of $450M in 9.500% senior secured notes due 2033 on October 9, 2026. The company plans to use net proceeds to refinance existing credit facilities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed